Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
Rhea-AI Impact
Rhea-AI Sentiment
Rhea-AI Summary
Oculis (OCS) has announced the filing of notifications regarding annual equity incentive awards granted to its board directors. The notifications specifically pertain to transactions by T Rosenberg, C Ackermann, A Khanani, and R Warner as part of the June 2025 Board of Directors grant program. These disclosures are standard regulatory filings required for transactions by persons discharging managerial responsibilities within the company.
Oculis (OCS) ha annunciato la presentazione delle notifiche relative alle assegnazioni annuali di incentivi azionari concesse ai membri del suo consiglio di amministrazione. Le notifiche riguardano specificamente le transazioni effettuate da T Rosenberg, C Ackermann, A Khanani e R Warner nell'ambito del programma di assegnazione del Consiglio di Amministrazione di giugno 2025. Queste comunicazioni rappresentano dichiarazioni regolamentari standard richieste per le transazioni effettuate da persone con responsabilità manageriali all'interno dell'azienda.
Oculis (OCS) ha anunciado la presentación de notificaciones relacionadas con las concesiones anuales de incentivos de acciones otorgadas a sus directores del consejo. Las notificaciones se refieren específicamente a las transacciones realizadas por T Rosenberg, C Ackermann, A Khanani y R Warner como parte del programa de concesión del Consejo de Administración de junio de 2025. Estas divulgaciones son presentaciones regulatorias estándar requeridas para transacciones realizadas por personas que desempeñan responsabilidades gerenciales dentro de la empresa.
Oculis(OCS)는 이사회 이사들에게 부여된 연간 주식 인센티브 수상에 관한 신고서를 제출했다고 발표했습니다. 이 신고서는 2025년 6월 이사회 보조금 프로그램의 일환으로 T Rosenberg, C Ackermann, A Khanani, R Warner의 거래에 관한 것입니다. 이러한 공시는 회사 내에서 경영 책임을 수행하는 인물들의 거래에 대해 요구되는 표준 규제 신고입니다.
Oculis (OCS) a annoncé le dépôt de notifications concernant les attributions annuelles de primes incitatives en actions accordées à ses administrateurs. Ces notifications concernent spécifiquement les transactions réalisées par T Rosenberg, C Ackermann, A Khanani et R Warner dans le cadre du programme d'attribution du conseil d'administration de juin 2025. Ces divulgations sont des déclarations réglementaires standard requises pour les transactions effectuées par des personnes exerçant des responsabilités de gestion au sein de l'entreprise.
Oculis (OCS) hat die Einreichung von Mitteilungen bezüglich der jährlichen Aktienanreizprämien bekannt gegeben, die seinen Vorstandsmitgliedern gewährt wurden. Die Mitteilungen beziehen sich speziell auf Transaktionen von T Rosenberg, C Ackermann, A Khanani und R Warner im Rahmen des Vergabeprogramms des Vorstands im Juni 2025. Diese Offenlegungen sind standardmäßige regulatorische Meldungen, die bei Transaktionen von Personen mit leitenden Funktionen im Unternehmen erforderlich sind.
Positive
- None.
Negative
- None.
ZUG, Switzerland, June 09, 2025 (GLOBE NEWSWIRE) -- The attached notifications relate to the annual equity incentive awards granted to directors of the Company.
Attachments
- Notification of managers' transaction - T Rosenberg - June 2025 BOD grant
- Notification of managers' transaction - C Ackermann- June 2025 BOD grant
- Notification of managers' transaction - A Khanani - June 2025 BOD grant
- Notification of managers' transaction - R Warner - June 2025 BOD grant
FAQ
What type of transactions did Oculis (OCS) disclose in June 2025?
Oculis disclosed notifications regarding annual equity incentive awards granted to its board directors T Rosenberg, C Ackermann, A Khanani, and R Warner.
Who are the Oculis (OCS) board members receiving equity incentive awards in June 2025?
The board members receiving equity incentive awards are T Rosenberg, C Ackermann, A Khanani, and R Warner.
What is the purpose of Oculis (OCS) managers' transaction notifications?
These notifications are regulatory requirements to disclose transactions by persons discharging managerial responsibilities, specifically regarding their annual equity incentive awards.
When were the Oculis (OCS) board director grants issued?
The board director grants were issued in June 2025 as part of the company's annual equity incentive award program.
Oculis Holding